- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
University of Arizona Cancer Center | Strategic Alliance Partners
The University of Arizona Cancer Center has been an NCI Designated Comprehensive Cancer Center for more than three decades, and is the only NCI Designated Comprehensive Cancer Center headquartered in the State of Arizona. The Cancer Center is uniquely poised to serve the needs of its diverse catchment area and address health disparities throughout the United States. UACC is leading the way by fostering innovation in collaborative research and cancer care.
Connect with us:
Latest from University of Arizona Cancer Center
Adverse Events Associated With Immunotherapy in the Treatment of Endometrial Cancer
July 04, 2023
Video
Christian Marth, MD, PhD, reviews the adverse effects of pembrolizumab and lenvatinib in the treatment of endometrial cancer, as well as the patient experience with these treatments.
Treatment Strategies in Non-Responders to Chemotherapy
July 04, 2023
Video
Bradley J. Monk, MD, FACS, FACOG, and Christian Marth, MD, PhD, share treatment approaches to patients with endometrial cancer with a low response rate to chemotherapy, highlighting a biomarker-based approach.
Clinical Trials of Immunotherapies in Endometrial Cancer
June 27, 2023
Video
Christian Marth, MD, PhD, and Bradley J. Monk, MD, FACS, FACOG, discuss data from the NRG GY018 and RUBY trials regarding the use of immunotherapies for the treatment of endometrial cancer.
Chemotherapy Options for Endometrial Cancer
June 20, 2023
Video
Bradley J. Monk, MD, FACS, FACOG, reviews the available chemotherapy options for treating advanced and recurrent endometrial cancer, as well as compares notes with Christian Marth, MD, PhD, on his clinical experience.
An Overview of Endometrial Cancer
June 20, 2023
Video
Christian Marth, MD, PhD, discusses the prevalence of endometrial cancer, as well as the steps that lead to diagnosis.
Future Outlook of Advanced Ovarian Cancer Treatment
May 30, 2023
Video
Comprehensive insights on unmet needs, ongoing research, and the future of advanced ovarian cancer treatment.
Advanced Ovarian Cancer: Current Treatment Landscape in Second- and Later-Line Settings
May 30, 2023
Video
Expert oncologists review the current PARP inhibitor treatment indications for patients with advanced ovarian cancer and discuss how to best manage patients who have been impacted by the recent updates to the PARP inhibitors.
Advanced Ovarian Cancer: Updated Indications for PARP Inhibitors in Second- and Later-Line Settings
May 30, 2023
Video
Drs Coleman and Monk discuss what led to the recent withdrawal of several indications for PARP inhibitors in the treatment of advanced ovarian cancer.
Role of PARP Inhibitors in Advanced Ovarian Cancer
May 30, 2023
Video
Expert oncologists give an overview of PARP inhibitors available for the treatment of patients with advanced ovarian cancer and review adverse events seen with each agent.
Role of Biomarkers in Advanced Ovarian Cancer
May 30, 2023
Video
Experts on advanced ovarian cancer give detailed insights on the role of biomarker testing and identify important biomarkers.
Overview of Advanced Ovarian Cancer
May 30, 2023
Video
Robert L Coleman, MD, FACOG, FACS, and Bradley J Monk, MD, FACOG, FACS, provide an overview of advanced ovarian cancer and discuss its prevalence and diagnosis process.
$10.8M Initiative Unites Engineering and Health Researchers to Improve Cancer Treatments
March 27, 2023
Article
A University of Arizona project, with funding from the state's New Economy Initiative, creates humanlike cancer models and growth environments to help improve prevention, diagnosis and treatment.
Cancer Center Leader Appointed to Establish Inaugural Office
March 20, 2023
Article
Jennifer Hatcher, PhD, RN, MPH, has been appointed as associate director of Inclusivity, Diversity, Equity and Accessibility for the University of Arizona Cancer Center.